Home » DUSA Pharmaceuticals Reports Notice of Allowance for Key PDT Device Patent
DUSA Pharmaceuticals Reports Notice of Allowance for Key PDT Device Patent
DUSA Pharmaceutical, a dermatology company that is developing
and marketing Levulan Photodynamic Therapy (PDT), announced that the United States Patent and Trademark Office has issued a notice of allowance for a key
patent related to its proprietary PDT light source, the BLU-U, Blue Light Photodynamic Therapy Illuminator.
MSN
MSN
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May